Impact of Apalutamide in Metastatic Hormone Sensitive Prostate Cancer Patients
Condition: Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Intervention: Sponsors: Royal Marsden NHS Foundation Trust; Janssen, LP Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2023 Category: Research Source Type: clinical trials